Methionine Requirements During Healthy Human Pregnancy
1 other identifier
interventional
69
1 country
1
Brief Summary
The current recommendations for dietary amino acid intake in pregnant women are based on calculations from requirements of adult men. The study aims to determine methionine requirements during early (11-20 weeks) and late (31-38 weeks) stages of pregnancy. Methionine, an essential amino acid (building block of body protein), is necessary for protein synthesis and for DNA related cellular functions. A non-invasive, novel method based on different diets, stable isotopes (the safe kind) and simple breath collection will be used. This method has recently been used by our laboratory to study other amino acids during pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2020
CompletedFirst Posted
Study publicly available on registry
March 30, 2020
CompletedStudy Start
First participant enrolled
September 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedFebruary 12, 2026
February 1, 2026
2.8 years
March 26, 2020
February 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The rate of oxidation of 13C phenylalanine.
Urine, breath and a single blood sample will be collected during the study to measure the rate of oxidation of 13C phenylalanine.
8 hours
Study Arms (1)
Methionine Intake
EXPERIMENTALOral consumption of eight hourly experimental meals- Includes 4 tracer-free experimental meals containing a mixture of free amino acids, calories from a flavored liquid and protein free cookies and 4- labeled amino acid experimental meals.
Interventions
Intakes will be randomly chosen from a list of 7 doses of methionine. Each intake will will be repeated approximately 5 times.
Eligibility Criteria
You may qualify if:
- Women who are 20-40 years of age. This includes women of reproductive age who have a low relative risk ratio of maternal or neonatal morbidities.
- Women pregnant with a singleton pregnancy.
- Women who are 11-20 or 31-40 weeks pregnant.
- In apparently good health. Subjects must not have pre-existing health conditions.
You may not qualify if:
- Women who are not pregnant or who are pregnant with more than one fetus.
- Women who were pregnant in the 6 months before the current pregnancy
- Women with history of spontaneous abortion (within the last 6 months) or pre-term birth
- Women who are younger than 20 years of age and older than 40 years of age.
- Women with a metabolic, neurological, genetic or immune disorder likely to affect nutritional requirements or overall body metabolism.
- \. Women who depend on medication that affects normal metabolism. 6. Women experiencing severe nausea, food avoidance or vomiting throughout their pregnancy.
- \. Women allergic to eggs or egg protein. 8. Women classified as underweight (\<18.5 kg/m2), overweight (25-30 kg/m2) or obese (\>30 kg/m2).
- \. Women smoking cigarettes, taking illicit drugs, or consuming alcohol regularly during their pregnancy.
- \. Women who do not take a prenatal vitamin for the duration of their study period.
- \. Women who have lost weight (approximately 1.5kg or more) during their current pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BC Children's Hospital Research Institute
Vancouver, British Columbia, V5Z4H4, Canada
Related Publications (1)
Scherbinsky K, Rasmussen BF, Li B, Kong D, Ball RO, Pencharz PB, Courtney-Martin G, Elango R. Total sulfur amino acid requirements are higher during late gestation compared with early gestation in healthy Canadian pregnancies in a repeated-measures trial. Am J Clin Nutr. 2024 Oct;120(4):973-983. doi: 10.1016/j.ajcnut.2024.07.034. Epub 2024 Aug 10.
PMID: 39128498DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Rajavel Elango, PhD
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 26, 2020
First Posted
March 30, 2020
Study Start
September 14, 2020
Primary Completion
June 21, 2023
Study Completion
June 1, 2024
Last Updated
February 12, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share